Ep.2- Balancing Benefits & Risks of IGF-1R Therapy With Drs. Raymond Douglas and Andrea Lora Kossler

Dr. Raymond Douglas - Optimizing TED Therapy: Minimally Invasive Options

Thyroid Eye Disease- causes, symptoms, diagnosis, treatment, pathology

Tepezza™ for Thyroid Eye Disease Active Phase

My Thoughts on Tepezza and Thyroid Eye Disease

Long-Term Data Testing Treatment in Patients With Thyroid Eye Disease

Teprotumomab for treatment of thyroid eye disease or Grave's orbitopathy (New Drug 2020)

AAO 2019: Update on TEPEZZA for treatment of TED

Illustrating the Progression of Thyroid Eye Disease

iIGFD Etiology

Dr. Douglas' Research in Thyroid Eye Disease

The longevity advantage of genetic deficiencies in growth hormone/IGF-1 signaling | Valter Longo

Insulin like growth factor I

Impaired TRH action in IGSF1-deficiency syndrome

Lecture: Thyroid Eye Disease: Past, Present, and Future

Thyroid Eye Disease Support Group - Understanding Thyroid Eye Disease Treatment (Part 6)

Experimental drug holds promise for the treatment of thyroid eye disease

RPB Lunch & Learn: Thyroid Eye Disease

Thyroid Eye Disease What Have We Learned Through Research

Thyroid Eye Disease